Gordon Findlay, a Novo Nordisk executive, suddenly collapsed while standing behind President Donald Trump during a press event in the Oval Office. The announcement was related to a new agreement on weight-loss medications.
Findlay's knees gave way unexpectedly, causing concern among those present. Officials from the administration and representatives from the pharmaceutical sector rushed to assist him and prevent a fall.
White House Press Secretary Karoline Leavitt confirmed that during the "Most Favored Nations Oval Office Announcement," a company representative fainted. She noted that on-site medical personnel promptly responded and confirmed the individual was okay.
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”
According to press witnesses, Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, assisted Findlay to the ground to prevent head injury. The press was then asked to leave the room while cabinet members tended to him and elevated his legs.
The press conference soon resumed as normal, following the medical intervention and assessment of Findlay’s condition.
“The Press Conference will resume shortly.”
Summary: During a White House announcement on weight-loss drugs, a Novo Nordisk executive fainted but received immediate medical care, allowing the event to continue without major disruption.